Henriikka Hakomäki[Author] - Search Results

Year	Number of Results
2020	1
2021	3
2022	1
2023	1
2024	2

1

Electrophilic metabolites targeting the KEAP1/NRF2 partnership.

Dinkova-Kostova AT, Hakomäki H, Levonen AL. Dinkova-Kostova AT, et al. Among authors: hakomaki h. Curr Opin Chem Biol. 2024 Feb;78:102425. doi: 10.1016/j.cbpa.2024.102425. Epub 2024 Jan 18. Curr Opin Chem Biol. 2024. PMID: 38241876 Free article. Review.

2

Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection.

Hakomäki H, Kokki H, Lehtonen M, Ranta VP, Räsänen J, Voipio HM, Kokki M. Hakomäki H, et al. Pharmacol Res Perspect. 2021 Apr;9(2):e00726. doi: 10.1002/prp2.726. Pharmacol Res Perspect. 2021. PMID: 33619904 Free PMC article. Review.

3

Intranasal Fentanyl for Intervention-Associated Breakthrough Pain After Cardiac Surgery.

Valtola A, Laakso M, Hakomäki H, Anderson BJ, Kokki H, Ranta VP, Rinne V, Kokki M. Valtola A, et al. Among authors: hakomaki h. Clin Pharmacokinet. 2021 Jul;60(7):907-919. doi: 10.1007/s40262-021-01002-4. Epub 2021 Mar 9. Clin Pharmacokinet. 2021. PMID: 33686630 Free PMC article. Clinical Trial.

4

Central nervous system distribution of buprenorphine in pregnant sheep, fetuses and newborn lambs after continuous transdermal and single subcutaneous extended-release dosing.

Hakomäki H, Eskola S, Kokki H, Lehtonen M, Räsänen J, Laaksonen S, Voipio HM, Ranta VP, Kokki M. Hakomäki H, et al. Eur J Pharm Sci. 2022 Nov 1;178:106283. doi: 10.1016/j.ejps.2022.106283. Epub 2022 Aug 24. Eur J Pharm Sci. 2022. PMID: 36029997 Free article.

5

Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing.

Härkänen L, Hakomäki H, Huopio J, Kokki H, Korhonen S, Lehtonen M, Sjövall S, Kokki M. Härkänen L, et al. Among authors: hakomaki h. Eur J Clin Pharmacol. 2023 Dec;79(12):1709-1711. doi: 10.1007/s00228-023-03583-4. Epub 2023 Oct 21. Eur J Clin Pharmacol. 2023. PMID: 37864723 Free PMC article.

6

Single dose epidural hydromorphone in labour pain: maternal pharmacokinetics and neonatal exposure.

Puhto T, Kokki M, Hakomäki H, Spalding M, Gunnar T, Alahuhta S, Vakkala M. Puhto T, et al. Among authors: hakomaki h. Eur J Clin Pharmacol. 2020 Jul;76(7):969-977. doi: 10.1007/s00228-020-02880-6. Epub 2020 May 3. Eur J Clin Pharmacol. 2020. PMID: 32363420 Free PMC article.

7

MATERNAL AND FETAL BUPRENORPHINE PHARMACOKINETICS IN PREGNANT SHEEP DURING TRANSDERMAL PATCH DOSING: Buprenorphine pharmacokinetics in pregnant sheep.

Hakomäki H, Kokki H, Lehtonen M, Räsänen J, Voipio HM, Ranta VP, Kokki M. Hakomäki H, et al. Eur J Pharm Sci. 2021 Oct 1;165:105936. doi: 10.1016/j.ejps.2021.105936. Epub 2021 Jul 14. Eur J Pharm Sci. 2021. PMID: 34273481 Free article.

8

Breast milk oxycodone concentrations in mothers given oxycodone for post-Caesarean delivery pain management.

Pesonen A, Hakomäki H, Kokki H, Ranta VP, Rinne V, Kokki M. Pesonen A, et al. Among authors: hakomaki h. Br J Clin Pharmacol. 2024 Apr;90(4):1183-1192. doi: 10.1111/bcp.16008. Epub 2024 Feb 2. Br J Clin Pharmacol. 2024. PMID: 38308454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year